« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 12
, Pages 1106-1114
, December 2009
The Obesity Paradox, Weight Loss, and Coronary Disease
References
- . AOA Fact Sheets: Obesity in the U.S.. Washington, DC: American Obesity Association; 2002;http://www.obesity.org/subs/fastfacts/obesity_US.shtmlAccessed April 2007
- . Obesity and cardiovascular disease: the Hippocrates paradox?. J Am Coll Cardiol. 2003;42(4):677–679
- . Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes. J Cardiopul Rehab. 2005;25:59–66
- . Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr. 2008;3(3):162–167
- . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–977
- . Obesity and cardiovascular disease—risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–1932
- The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
- . Body composition and prognosis in chronic systolic heart failure—the obesity paradox. Am J Cardiol. 2003;91:891–894
- The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61
- . Obesity and heart failure prognosis: paradox of reverse epidemiology?. Eur Heart J. 2005;26:5–7
- Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol. 2007;100:1460–1464
- Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863–870
- . Obesity, heart disease, and favorable prognosis—truth or paradox?. Am J Med. 2007;120:825–826
- Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–678
- . Adiposity and cardiovascular disease: are we using the right definition of obesity?. Eur Heart J. 2007;28:2047–2048
- Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J. 2007;28:2087–2093
- The association of differing measures of overweight and obesity with prevalent atherosclerosis. J Am Coll Cardiol. 2007;50:752–759
- . Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28:850–856
- . Differentiating between body fat and lean mass how should we measure obesity?. Nat Clin Pract Endocrinol Metab. 2008;4(6):322–323
- AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services: endorsed by the American college of chest physicians, American college of sports medicine, American physical therapy association, Canadian association of cardiac rehabilitation, European association for cardiovascular prevention and rehabilitation, inter-American heart foundation, national association of clinical nurse specialists, preventive cardiovascular nurses association, and the society of thoracic surgeons. J Am Coll Cardiol. 2007;50:1400–1433
- . Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review. Am Heart J. 2006;151:249–256
- . Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345:892–902
- Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J. 2006;152:835–841
- . Patients with high baseline exercise capacity benefit from cardiac rehabilitation and exercise training programs. Am Heart J. 1994;128(6, pt 1):1105–1109
- . Effects of cardiac rehabilitation and exercise training on low density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol. 1994;74:1192–1195
- Surgeon General's report on physical activity and health (From the Centers for Disease Control and Prevention). JAMA. 1996;276:522
- . Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol. 2004;43:1056–1061
- Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J. 2002;143:977–983
- . Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J. 2002;143(2):349–355
- . Prevalence of hostility in young coronary patients and effects of cardiac rehabilitation and exercise training. Mayo Clin Proc. 2005;80:335–342
- . Prevalence of anxiety in coronary patients with improvements following cardiac rehabilitation and exercise training. Am J Cardiol. 2004;93:336–339
- . Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med. 2006;166:1878–1883
- . Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007;120:799–806
- . Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA. 1998;260:945–950
- An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;80(2):234–244
- . Cardiac rehabilitation in obese patients. Chest. 1996;109:3–4
- . Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol. 1997;79:397–401
- . Exercise training in special populations: obesity. In: Wenger NK, Smith LK, Froelicher ES, Comoss PM editor. Cardiac Rehabilitation: A Guide to Practice in the 21st Century. New York: Marcel Dekker Inc; 1999;p. 151–154
- Obesity, weight reduction and survival in heart failure: reply. J Am Coll Cardiol. 2002;39:1563–1564
- Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies. Int J Obes Relat Metab Disord. 1999;23(6):603–611
- Physical status: the use and interpretation of anthropometry (Report of a WHO expert committee). World Health Organ Tech Rep Ser. 1995;854:1–452
- . Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea?. Circulation. 2004;110:e27–e31
- . Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc. 2006;81(12):1603–1611
- . Practical assessment of body composition. Physician Sports Med. 1985;13:76–90
- . A symptom questionnaire. J Clin Psychiatry. 1987;48:268–274
- Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J. 2005;26:58–64
- Disparate effects of obesity and left ventricular geometry on mortality in 8,088 elderly with preserved systolic function. Postgrad Med J. 2009;121:119–125
- . Body mass, fitness and survival in veteran patients: another obesity paradox?. Am J Med. 2007;120:518–524
- The effect of sex, age and race on estimating percentage body fat from body mass index: the heritage family study. Int J Obes Relat Metab Disord. 2002;26:689–796
- Relationships between the body mass index and body composition. Obes Res. 1996;4:35–44
- Assessing the validity of body mass index standards in early postmenopausal woman. Obes Res. 2002;10:799–808
- Does body composition impact survival in patients with advanced heart failure. Circulation. 2007;116(16):11–360
- . Untangling the heavy cardiovascular burden of obesity. Nat Clin Pract Cardiovasc Med. 2008;5(7):428–429
- Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43(9):1590–1595
- . Impact of obesity on the risk of heart failure and its prognosis. J Cardiometabol Synd. 2008;3:155–161
- . Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metat Disord. 2004;28(Suppl 4):S12–S21
- . Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005;33(Pt 5):1078–1081
- Is adiposopathy (“sick fat”) an endocrine disease?. Int J Clin Pract. 2008;10:1474–1483
- Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral. Expert Rev Cardiovasc Ther. 2008;3:343–368
- . Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–2556
- . Weight loss causes increased mortality: pros. Obes Rev. 2003;4(1):3–7
- Relationship between leptin, C-reactive protein and obesity with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med. 2008;5(7):418–425
- . Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol. 2005;161:352–358
- Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil. 2008;15:336–340
- The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000;36:2126–2131
Funding: None.
Conflict of Interest: The authors have no conflict of interest regarding this study.
Authorship: This is an original work and all authors meet the criteria for authorship, including acceptance of responsibility for the scientific content of this manuscript. All authors had access to the data and had roles in writing and revising the manuscript.
PII: S0002-9343(09)00500-2
doi: 10.1016/j.amjmed.2009.06.006
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 12
, Pages 1106-1114
, December 2009

